Showing results (171-180 of 197) with videos related to

Sort By:
Pageof 20
Nature Communications|December 27, 2025
Ribosome biogenesis as a potential therapeutic target in KRAS mutant colorectal cancerYui Tanaka, Mizuho Sakahara, Hitomi Yamanaka, et al.
Annals of Surgical Oncology|April 10, 2019
Phase II Trial of Neoadjuvant Chemotherapy, Chemoradiotherapy, and Laparoscopic Surgery with Selective Lateral Node Dissection for Poor-Risk Low Rectal CancerTsuyoshi Konishi, Eiji Shinozaki, Keiko Murofushi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 14, 2012
[A case of transverse colon cancer with multiple liver metastases and hepatic pedicle lymph node involvement showing pathological complete response by XELOX plus bevacizumab]Toshiki Mukai, Takashi Akiyoshi, Rintaro Koga, et al.
Asian Journal of Endoscopic Surgery|August 4, 2024
Low-grade appendiceal mucinous neoplasm penetrating sigmoid colon: A case reportMichio Okamoto, Ryosuke Okamura, Yoshiro Itatani, et al.
Asian Journal of Endoscopic Surgery|April 13, 2019
Laparoscopic-endoscopic cooperative surgery for ileal lipoma: A case reportRyota Nakanishi, Yosuke Fukunaga, Toshiya Nagasaki, et al.
Oncoimmunology|May 10, 2019
TCR sequencing analysis of cancer tissues and tumor draining lymph nodes in colorectal cancer patientsTatsuo Matsuda, Eisaku Miyauchi, Yu-Wen Hsu, et al.
International Journal of Cancer|March 24, 2016
RAS mutation is a prognostic biomarker in colorectal cancer patients with metastasectomyHiroki Osumi, Eiji Shinozaki, Mitsukuni Suenaga, et al.
Stem Cell Reports|March 12, 2021
Comparative Analysis of Patient-Matched PDOs Revealed a Reduction in OLFM4-Associated Clusters in Metastatic Lesions in Colorectal CancerTakuya Okamoto, David duVerle, Katsuyuki Yaginuma, et al.
Communications Biology|December 28, 2022
RNaseH2A downregulation drives inflammatory gene expression via genomic DNA fragmentation in senescent and cancer cellsSho Sugawara, Ryo Okada, Tze Mun Loo, et al.
British Journal of Cancer|November 16, 2023
APC/PIK3CA mutations and β-catenin status predict tankyrase inhibitor sensitivity of patient-derived colorectal cancer cellsMingjue Chen, Tetsuo Mashima, Taichi Oishi, et al.
Pageof 20